Scientists developed a nebulized nanocatalytic medicine strategy in which iron-based nanoparticle-regulated tumor-associated macrophages effectively target CSC niches and trigger CSC ferroptosis in the early stage of lung cancer.
[Journal Of The American Chemical Society]